First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial
We have improved our eMediNexus Platform with a far superior user experience.
Please click here to try it
Editor-in-Chief eMediNexus – Dr KK Aggarwal
 
28th September 2018
Saving a death when we cannot save a life in the intensive care unit

Dr KK Aggarwal, Recipient of Padma Shri

There are several situations and/or elective interventions in medicine where the patient is made unconscious, given anesthesia, surgery or sedation especially in terminally ill patients. In these situations, there is a chance that the patient may not wake up. Even though the intervention may have been necessary, it deprives them of their chance to share few last words with their families.

In the June 2018 issue of JAMA International Medicine, Michael E. Wilson - a critical care doctor - has written an account of a woman in intensive care in "Saving a death when we cannot save a life in the intensive care unit", who was electively intubated for a procedure and then died, without ever having had the opportunity for her loved ones to say goodbye.

This can be somewhat likened to soldiers being sent off to war by their families with a puja and tika or families sending off their loved one on a pilgrimage or tirth yatra with a tika in ancient times as they may not come back alive. ...read more

Video Of The Day : Jugadu Catering
Top News

Today is World Rabies Day: "Share the message. Save a life"

World Rabies Day is celebrated annually to raise awareness about rabies prevention and to highlight progress in defeating this horrifying disease. The day also marks the anniversary of Louis Pasteur's death, the French chemist and microbiologist, who developed the first rabies vaccine. Today, safe and efficacious animal and human vaccines are among the important .... read more

Elimination of dog-transmitted rabies by 2030 targeted

The total elimination of dog-transmitted human rabies by 2030 has been called for in a joint statement by the World Veterinary Association (WVA) and World Medical Association (WMA). The two organizations have joined forces to mark World Rabies Day on September 28 in collaboration with the Rabies: Share the message - Save a life campaign of Global Alliance for Rabies Control (GARC).... read more

Morning Medtalks

Morning MEDtalks with Dr KK Aggarwal 28th September 2018

Dear Colleague Here are two links for videos to watch. Share them with your colleagues and friends.
• What is FDC? https://www.youtube.com/watch?v=tGv6BRIG8UA
• TEDx Video: Doctor-patient relationship https://www.youtube.com/watch?v=i9ml1vKK2DQ
Lp(a) can be reduced: Treatment with a proprietary antisense agent was associated with significant reductions in levels of lipoprotein(a) in a phase 2 study of patients with established coronary or peripheral vascular disease and elevated Lp(a). The observed reductions in Lp(a) occurred at all tested dosage levels of the drug, called AKCEA-APO(a)-LRx (Akcea/Ionis)... read more

Practice Updates

Breastfed babies are less likely to be obese

In a study published online Sept. 24 in the journal Pediatrics, researchers found that breastfeeding was associated with lower body mass index (BMI) and a reduced risk of excessive weight gain in the first year of life. This trend was stronger with longer and more ... read more


Study shows cardiovascular safety of lorcaserin in overweight or obese patients

In a high-risk population of overweight or obese patients, lorcaserin 10 mg twice daily facilitated sustained weight loss without a higher rate of major cardiovascular events than that with placebo. At 1 year, weight loss of at least 5% had occurred in 38.7% patients in the ... read more


Baricitinib dose reduction feasible in RA patients achieving sustained disease control

In a large randomized, blinded phase 3 study published September 7,2017 in the Annals of the Rheumatic Diseases, maintenance of rheumatoid arthritis (RA) control following induction of sustained low disease activity (LDA) or remission (REM) with baricitinib 4 mg... read more


FDA approves Augmented Reality GLOW800Fluorescence for vascular neurosurgery

The US Food and Drug Administration (FDA) has cleared Leica Microsystems' augmented reality (AR) GLOW800 surgical fluorescence for vascular neurosurgery. In combination with ICG (Indocyanine Green), GLOW800 allows surgeons to observe cerebral anatomy in natural color, augmented by real-time vascular flow in a single image, with full depth ... read more


NIRS-IVUS detects patients and plaques vulnerable to subsequent adverse coronary events

Results from the Lipid-Rich Plaque (LRP) study have shown a correlation between the presence of non-flow-limiting, non-intervened upon, lipid-rich plaques detected by NIRS-IVUS imaging and the development of a major adverse cardiac event (MACE) from a de novo culprit lesion at both the patient level (vulnerable patients) and segment level ... read more

eMedi Humor
Medicolegal Corner
eMedi Quiz
1. Pemphigus vulgaris.
2. Pemphigoid.
3. Erythema multiforme.
4. Dermatitis herpetiformis.
Lifestyle Updates
 
Inspirational Story 1: God has a Sense of Humor Too
Inspirational Story 2: God has a Sense of Humor Too
Contact tracing imperative to achieve the target of ending tuberculosis in India
Early diagnosis with GeneXpert sputum test a must
 
New Delhi, 27 September 2018: Governments of various countries have agreed to contribute $13 billion a year by 2022 to prevent and treat tuberculosis (TB), a communicable disease that claimed at least 1.3 million lives last year, as per the WHO.TB killed about 1.3 million people worldwide last year, making it the leading cause of death from an infectious disease ahead of HIV/AIDS. A further 300,000 people with both HIV and TB died in 2017.

Although TB has been successfully contained in developed nations, the poor and developing countries continue to record prevalence of this condition. There is also consensus that drug-resistant variants of this deadly communicable disease pose a growing threat, with India, China and Russia particular affected.

To Read More or Comment, Click Here